According to a media release issued by a Canadian company called Profound Medical on August 16, the US Food and Drug Administration (FDA) has approved the use of a system called TULSA-PRO for the “ablation of prostate tissue”. There appears to be no relevant information on the FDA web site — as yet. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ablation, energy, Profound, thermal, transurethral, TULSA-PRO, ultrasound | 8 Comments »
An important new paper in the Journal of Vascular and Interventional Radiology has just provided us with the first large set of data on the outcomes of men with prostate cancer treated with focal laser ablation (FLA). … READ MORE …
Filed under: Uncategorized | Tagged: ablation, focal, intermediate risk, laser, localized, low risk | 5 Comments »
A new review article offers us some greater clarity related to the role of targeted, high-intensity focused ultrasound (HIFU) to treat carefully selected areas of the prostate to eliminate primary or index lesions while leaving the remainder of the prostate intact. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ablation, focused, HIFU, high-intensity, partial, targeted, ultrasound | 2 Comments »
The development of drugs like abiraterone acetate and enzalutamide has stimulated new research into the use of such agents early on, in combination with first-line therapy, to see if it can affect the outcomes for men with high-risk and unfavorable intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ablation, androgen, enzalutamide, neoadjuvant, risk, surgery | Leave a comment »
Last Tuesday, through the CureTalks service, we held an hour-long discussion with Dr. Ara Karamanian about the evolving and potential role of focal laser ablation (FLA) in the management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ablation, CureTalks, FLA, focal, laser | 4 Comments »
We reported several months ago on a pilot study of focal irreversible electroporation (IRE or NanoKnife®) in Sydney and London. … READ MORE …
Filed under: Management, Treatment | Tagged: ablation, NanoKnife, pilot, Treatment | 7 Comments »
A major plenary presentation at the upcoming annual meeting of the American Urological Association (AUA) will provide data from a rather small French trial of high-intensity focused ultrasound (HIFU) in the focal management of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: ablation, focal, hemiablation, HIFU, high-intensity, outcome, ultrasound | Leave a comment »
… after you pass away, this is the sort of study that you may be able to watch it be used for (always assuming that there is actually a life after death and that you have the ability to observe what happens to your prior “vessel”). … READ MORE …
Filed under: Management, Treatment | Tagged: ablation, focal therapy, laser | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 